Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00591240 · ClinicalTrials.gov registry record
A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 338
- Enrollment target
NCT00591240: Completed study, sponsored by VA Office of Research and Development.
NCT00591240 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 338 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00591240 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 338 participants
- Enrollment target
Study Summary
The purpose of this proposal is clinical validation of an electrochemical biochip for rapid pathogen identification and antibiotic susceptibility determination.
Primary Outcome
Study 1: Multiplex pathogen identification using biosensor based assay. We recruited 116 participants yielding 109 urine samples suitable for analysis and comparison between biosensor assays and standard urine culture. Biosensor based assays were used to detect multiple pathogens in the urine samples. Study 2: Antimicrobial susceptibility testing using biosensor based assay. We recruited 222 participants yielding 252 urine samples. Corresponding biosensor and clinical microbiology culture data
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-06 |
What the finished NCT00591240 record still lists
NCT00591240 is an observational study that tracks outcomes without assigning an intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00591240 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00591240 about?
NCT00591240 is a clinical study titled "A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection". The purpose of this proposal is clinical validation of an electrochemical biochip for rapid pathogen identification and antibiotic susceptibility determination.
What is the current status of trial NCT00591240?
This trial is currently completed. The enrollment target is 338 participants. The study started on 2007-07. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT00591240?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia